Hims & Hers Health, Inc. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the period ended September 30, 2026, disclosing substantial growth in total assets and significant changes to its balance sheet compared to December 31, 2025.

Key Highlights

  • Total assets of $3,546,862 thousand as of September 30, 2026, up from $2,154,705 thousand at December 31, 2025, according to the filing.
  • Cash and cash equivalents of $605,604 thousand as of September 30, 2026, compared to $228,616 thousand at December 31, 2025.
  • Goodwill rose to $1,110,684 thousand as of September 30, 2026, from $278,325 thousand at December 31, 2025, reflecting acquisition activity during the period.
  • Receivables, net, of $427,847 thousand as of September 30, 2026, compared to $32,149 thousand at December 31, 2025.
  • Deferred acquisition payable of $478,595 thousand as of September 30, 2026, versus $1,479 thousand at December 31, 2025.
  • 226,034,799 shares of Class A common stock and 8,377,623 shares of Class V common stock were issued and outstanding as of November 6, 2026.

Hims & Hers Balance Sheet Shows Significant Shifts Through September 30, 2026

According to the quarterly report filed on NYSE:HIMS, Hims & Hers Health, Inc. reported total assets of $3,546,862 thousand as of September 30, 2026, an increase from $2,154,705 thousand recorded at December 31, 2025. The filing shows current assets grew to $1,321,102 thousand from $767,638 thousand over the same period, driven in part by a sharp increase in receivables, net, from $32,149 thousand to $427,847 thousand, as well as higher cash and cash equivalents.

The filing also discloses a marked increase in goodwill, rising to $1,110,684 thousand from $278,325 thousand at year-end 2025, alongside intangible assets, net, growing to $397,261 thousand from $196,116 thousand. These changes are consistent with acquisition activity reflected in the balance sheet. Property, equipment, and software, net, increased to $391,079 thousand from $311,930 thousand. On the liabilities side, accounts payable grew to $515,690 thousand from $143,278 thousand, and accrued liabilities rose to $200,100 thousand from $77,039 thousand.

Short-term available-for-sale investments declined to $106,617 thousand from $348,876 thousand, while long-term available-for-sale investments, which stood at $351,263 thousand at December 31, 2025, showed a balance of zero as of September 30, 2026, according to the filing. The deferred acquisition payable of $478,595 thousand in current liabilities as of September 30, 2026 compares to just $1,479 thousand at the prior year-end. The filing notes the company is classified as a large accelerated filer and is incorporated in Delaware, with principal offices in San Francisco, California. Forward-looking statements contained in the report are the company's own and are subject to its cautionary language as described in the filing.

What Was Disclosed

Hims & Hers Health, Inc. disclosed its condensed consolidated balance sheet data for the quarter ended September 30, 2026, showing material increases in total assets, goodwill, receivables, and certain liabilities compared to December 31, 2025, alongside its share counts as of November 6, 2026.